Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
2
|
|
Patent #:
|
|
Issue Dt:
|
06/25/2019
|
Application #:
|
15755122
|
Filing Dt:
|
02/26/2018
|
|
Publication #:
|
|
Pub Dt:
|
08/30/2018
| | | | |
|
Inventors:
|
Giordano Caponigro, Thomas Horn-Spirohn, Joseph Lehar
|
|
Title:
|
PHARMACEUTICAL COMBINATION COMPRISING THE PI3K INHIBITOR ALPELISIB AND THE B-RAF INHIBITOR DABRAFENIB; THE USE OF SUCH COMBINATION IN THE TREATMENT OR PREVENTION OF CANCER
|
|
|
Assignment:
1
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 250 MASSACHUSETTS AVENUE |
| CAMBRIDGE, MASSACHUSETTS 02139 |
|
|
|
|
| NOVARTIS PHARMACEUTICALS CORPORATION |
| 1 HEALTH PLAZA |
| EAST HANOVER, NJ 07936 |
|
|
|
Assignment:
2
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| LICHTSTRASSE 35 |
| BASEL, SWITZERLAND 4056 |
|
|
|
|
| NOVARTIS PHARMACEUTICALS CORPORATION |
| 1 HEALTH PLAZA |
| EAST HANOVER, NJ 07936 |
|
|
Search Results as of:
06/22/2025 02:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
